PMC · DOI:10.1002/hsr2.70101·September 25, 2024
Pharmaceutical industry payments to authors of neurology clinical practice guidelines in Japan: A cross‐sectional study
Anju Murayama, Yuki Senoo
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical industry and healthcare · Health Systems, Economic Evaluations, Quality of Life · Clinical practice guidelines implementation